A coalition of 80 institutional investors sent a
letter to Congress last week in support of the Business
Transparency on Trafficking and Slavery Act (HR 2759).
As discussed previously, the proposed legislation would require
companies to disclose efforts to identify and address the risks of
human trafficking, forced labor, slavery, and the worst forms of
child labor in their supply chains.
Modeled after the
California Transparency in Supply Chains Act, which went into
effect on January 1, 2012, the proposed federal legislation, unlike
the California statute, is not limited to retailers and
manufacturers. If enacted, the legislation would be applicable to
any publicly-traded or private company currently required to submit
annual reports to the Securities and Exchange Commission
("SEC"), as long as the company meets an established
annual gross receipts threshold. Companies would be required to
include the required disclosures in their annual reports to the
In a letter sent to Speaker of the House John Boehner and House
Majority Leader Eric Cantor, members of the Interfaith Center on
Corporate Responsibility and U.S. SIF: The Forum for Sustainable
and Responsible Investment called for HR 2759 to be placed at
the top of the legislative agenda in order to move "this
important legislation forward in an expeditious manner."
In urging Congressional leaders to prioritize the bill, the
investors stated that the proposed legislation
"reflects the realities of the marketplace, which
increasingly requires that companies be sensitive to social and
ethical issues, including human rights, in their operations and
global supply chains, and create human rights policies, as well as
due diligence processes to evaluate, monitor, and strengthen these
Notably, the investors' statement also argued that the U.N
Human Rights Council's unanimous endorsement of the
Guiding Principles on Business and Human Rights in June 2011
established "a global norm for the 'corporate
responsibility to respect' human rights and underscores the
importance of public reporting by companies."
When it was introduced in August 2011, HR 2759 was referred to
the House Committee on Financial Services and currently sits with
the Subcommittee on Capital Markets and Government Sponsored
Enterprises. Given the contentious climate on Capitol Hill, and the
upcoming presidential election, it is unlikely that the bill will
move in 2012, but its introduction is reflective of shifting
expectations regarding the responsibilities of companies to
identify and account for the adverse human rights impacts of their
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Foley Hoag will present a 60-minute webinar on Wednesday, January 25, 2017 at 12:30 pm EST offering guidance to in-house counsel on best practices for pharmaceutical and biologics companies in selecting, vetting, and seeking approval for medication product names. The focus will be primarily on the U.S. market, although foreign strategies may be addressed as well.
25 Jan 2017, Seminar, Massachusetts, United States
Please join us on Wednesday, January 25 at the Westin Waltham Hotel for our quarterly New England M&A Forum, which brings the latest in market trends and recent legal developments to the New England M&A professionals' community.
Sellers love them, buyers hate them, but auctions are a mainstay of the M&A landscape. Our panel of experts, led by Foley Hoag partner Bill Kolb, will discuss legal, business and strategic considerations in structuring and participating in auctions from both the buy-side and the sell-side.
On November 9, 2016 Andrew Liazos presented at the New York City Bar. He discussed innovative approaches used by public companies during the 2016 proxy season for disclosing executive compensation practices.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).